The groundbreaking treatment of tirzepatide peptide represents a major development in the care of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets two pathways – GLP-1 and https://tirzepatidepeptide200166.glifeblog.com/40606048/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment